• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于胃腺癌非侵入性诊断的新型树状结构分析。

A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.

作者信息

Wu M S, Lee W C, Lin J T, Wang H P, Wang T H, Chen C J

机构信息

Department of Internal Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

出版信息

Anticancer Res. 1995 Nov-Dec;15(6B):2739-43.

PMID:8669856
Abstract

Non-invasive diagnosis of gastric adenocarcinoma (GAC) is usually difficult due to the low sensitivity and specificity of serologic markers,including pepsinogens and gastrin. For the improvement of the diagnostic values of these markers, a "recursive partitioning and amalgamation" algorithm was employed to construct a decision protocol. A total of 636 subjects including 161 healthy subjects, 163 patients with GAC, 196 with gastric ulcer and 116 with duodenal ulcer were enrolled. Serum levels of gastrin, pepsinogen I, pepsinogen II, and the ratio of pepsinogen I / pepsinogen II were determined for each of the subjects. The proposed "decision tree" classifies subjects into five subgroups with different risks of GAC and peptic ulcer, based on the information of age, serum pepsinogen and gastrin levels. Using this novel analysis system, an expected probability of GAC or ulcers could be obtained. Patients with an age > 62 years and a serum level of pepsinogen I < or = 33 ng/ml were strongly indicated for further confirmatory tests of GAC. This treestructured analysis is also helpful in clarifying the interactions between various serologic markers and demographic factors.

摘要

由于包括胃蛋白酶原和胃泌素在内的血清学标志物的敏感性和特异性较低,胃腺癌(GAC)的非侵入性诊断通常较为困难。为了提高这些标志物的诊断价值,采用了一种“递归划分与合并”算法来构建决策方案。共纳入636名受试者,包括161名健康受试者、163名GAC患者、196名胃溃疡患者和116名十二指肠溃疡患者。测定了每位受试者的胃泌素、胃蛋白酶原I、胃蛋白酶原II水平以及胃蛋白酶原I/胃蛋白酶原II比值。基于年龄、血清胃蛋白酶原和胃泌素水平信息,所提出的“决策树”将受试者分为GAC和消化性溃疡风险不同的五个亚组。使用这种新型分析系统,可以获得GAC或溃疡的预期概率。年龄>62岁且血清胃蛋白酶原I水平≤33 ng/ml的患者强烈提示需进一步进行GAC的确诊检查。这种树形结构分析也有助于阐明各种血清学标志物与人口统计学因素之间的相互作用。

相似文献

1
A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.一种用于胃腺癌非侵入性诊断的新型树状结构分析。
Anticancer Res. 1995 Nov-Dec;15(6B):2739-43.
2
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.通过血清胃蛋白酶原、胃泌素-17和幽门螺杆菌免疫球蛋白G抗体筛查萎缩性胃炎和胃癌。
J Dig Dis. 2007 Feb;8(1):15-22. doi: 10.1111/j.1443-9573.2007.00271.x.
3
Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.胃癌患者血清胃蛋白酶原I和胃泌素水平:幽门螺杆菌感染及肿瘤特征的影响
Hepatogastroenterology. 1993 Dec;40(6):600-3.
4
Diagnosis of gastric adenocarcinoma using a scoring system: combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin.使用评分系统诊断胃腺癌:幽门螺杆菌感染血清学标志物、胃蛋白酶原I和胃泌素的联合检测
J Gastroenterol. 1995 Apr;30(2):156-61. doi: 10.1007/BF02348659.
5
Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.幽门螺杆菌根除后长期监测中血清胃蛋白酶原和胃泌素的改善:与幽门螺杆菌阴性患者的比较。
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2004.01970.x.
6
Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.根除幽门螺杆菌可改善十二指肠溃疡患者的胃组织学状况,并降低其血清胃泌素、胃蛋白酶原I和胃蛋白酶原II水平。
J Gastroenterol Hepatol. 2008 Nov;23(11):1666-71. doi: 10.1111/j.1440-1746.2007.04983.x. Epub 2007 Jun 7.
7
Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.幽门螺杆菌根除对胃溃疡患者胃组织学、血清胃泌素和胃蛋白酶原I水平以及胃排空的影响。
Am J Gastroenterol. 1997 Oct;92(10):1844-8.
8
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?胃蛋白酶原A/胃蛋白酶原C或胃蛋白酶原A乘以胃泌素在胃癌诊断中的应用?
Ital J Gastroenterol. 1991 May;23(4):194-6.
9
Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs.使用非甾体抗炎药的消化性溃疡患者的血清胃蛋白酶原I和胃泌素
Hepatogastroenterology. 1997 Jul-Aug;44(16):1143-6.
10
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.日本和荷兰有或无溃疡病男性员工胃炎的血清流行病学
Eur J Gastroenterol Hepatol. 1996 Jan;8(1):33-9. doi: 10.1097/00042737-199601000-00007.

引用本文的文献

1
Gastric cancer screening using the serum pepsinogen test method.采用血清胃蛋白酶原检测方法进行胃癌筛查。
Gastric Cancer. 2006;9(4):245-53. doi: 10.1007/s10120-006-0397-0. Epub 2006 Nov 24.
2
Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group.幽门螺杆菌感染管理中的血液检测。意大利幽门螺杆菌研究小组。
Gut. 1998 Jul;43 Suppl 1(Suppl 1):S39-46. doi: 10.1136/gut.43.2008.s39.